These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Concomitant synthesis of growth factors and their receptors--an aspect of malignant transformation. Alexander P; Currie G Biochem Pharmacol; 1984 Mar; 33(6):941-3. PubMed ID: 6324807 [TBL] [Abstract][Full Text] [Related]
8. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Tsichlis PN; Lazo PA Curr Top Microbiol Immunol; 1991; 171():95-171. PubMed ID: 1667631 [No Abstract] [Full Text] [Related]
9. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies. Soma T; Dunbar CE Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810 [No Abstract] [Full Text] [Related]
12. Cellular epigenetics and the origin of cancer. Cuthill S Bioessays; 1994 Jun; 16(6):393-4. PubMed ID: 8080428 [No Abstract] [Full Text] [Related]
13. Molecular determinants of metastatic transformation. Egan SE; Wright JA; Greenberg AH Environ Health Perspect; 1991 Jun; 93():91-5. PubMed ID: 1773806 [TBL] [Abstract][Full Text] [Related]
14. Transformation-related growth factors and their receptors. Bregman MD; Sipes NJ Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097 [TBL] [Abstract][Full Text] [Related]
15. Growth factors and transformation. Roberts AB; Sporn MB Cancer Surv; 1986; 5(2):405-12. PubMed ID: 3779661 [TBL] [Abstract][Full Text] [Related]
16. Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal. Delle Fave G; Corleto VD Ann Oncol; 2001; 12 Suppl 2():S13-7. PubMed ID: 11762339 [TBL] [Abstract][Full Text] [Related]
17. Oncogenes, growth factors, and prognostic indicators in colorectal cancer. Rowley S; Newbold M; Neoptolemos JP Surg Annu; 1992; 24 Pt 2():59-85. PubMed ID: 1440150 [No Abstract] [Full Text] [Related]
18. Oncogenes: cause or consequence in the development of glial tumors. Akbasak A; Sunar-Akbasak B J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337 [TBL] [Abstract][Full Text] [Related]
19. Peptide regulatory factors and malignancy. Steel CM Lancet; 1989 Jul; 2(8653):30-4. PubMed ID: 2567802 [No Abstract] [Full Text] [Related]
20. [The morphofunctional aspects of the metastatic process in malignant tumors]. Herasymenko OI; Vasylenko IV Lik Sprava; 1993; (5-6):31-4. PubMed ID: 8209494 [No Abstract] [Full Text] [Related] [Next] [New Search]